These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4146555)

  • 1. Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.
    Bulat M; Zivković B
    J Pharm Pharmacol; 1973 Feb; 25(2):178-9. PubMed ID: 4146555
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport mechanisms in the cerebrospinal fluid system for removal of acid metabolites from developing brain.
    Bass NH; Lundborg P
    Adv Exp Med Biol; 1976; 69():31-40. PubMed ID: 941740
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development.
    Atack C; Bass NH; Lundborg P
    Brain Res; 1974 Aug; 77(1):111-20. PubMed ID: 4853133
    [No Abstract]   [Full Text] [Related]  

  • 4. A.E. Bennett Award Paper. A kinetic analysis of 5-hydroxyindoleacetic acid excretion from rat brain and csf.
    Burns D; London J; Brunswick DJ; Pring M; Garfinkel D; Rabinowitz JL; Mendels J
    Biol Psychiatry; 1976 Apr; 11(2):125-57. PubMed ID: 971444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?
    Meek JL; Neff NH
    Neuropharmacology; 1973 May; 12(5):497-9. PubMed ID: 4708479
    [No Abstract]   [Full Text] [Related]  

  • 6. On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine.
    Aizenstein ML; Korf J
    J Neurochem; 1979 Apr; 32(4):1227-33. PubMed ID: 430082
    [No Abstract]   [Full Text] [Related]  

  • 7. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine.
    Bowers MB
    J Neurochem; 1970 Jun; 17(6):827-8. PubMed ID: 5426662
    [No Abstract]   [Full Text] [Related]  

  • 9. Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid.
    Sjöström R
    Psychopharmacologia; 1972; 25(1):96-100. PubMed ID: 4261043
    [No Abstract]   [Full Text] [Related]  

  • 10. Exchange of 5-hydroxyindoleacetic acid between the spinal cord and lumbar cerebrospinal fluid.
    Bulat M; Zivković B
    J Physiol; 1978 Feb; 275():191-7. PubMed ID: 633105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-hydroxyindoleacetic acid transport from the spinal fluid by probenecid.
    Zivković B; Bulat M
    J Pharm Pharmacol; 1971 Jul; 23(7):539-40. PubMed ID: 4397456
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid and brain of different rabbit breeds after treatment with probenecid.
    Andersson H; Roos BE
    J Pharm Pharmacol; 1972 Feb; 24(2):165-6. PubMed ID: 4401976
    [No Abstract]   [Full Text] [Related]  

  • 14. Clearance of amine metabolites from the cerebrospinal fluid: the brain as a "sink".
    Wolfson LI; Katzman R; Escriva A
    Neurology; 1974 Aug; 24(8):772-9. PubMed ID: 4858421
    [No Abstract]   [Full Text] [Related]  

  • 15. The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.
    Young SN; Anderson GM; Gauthier S; Purdy WC
    J Neurochem; 1980 May; 34(5):1087-92. PubMed ID: 6154772
    [No Abstract]   [Full Text] [Related]  

  • 16. REM sleep and central monoamine oxidase inhibition.
    Kupfer DJ; Bowers MB
    Psychopharmacologia; 1972; 27(3):183-90. PubMed ID: 4345178
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrier.
    Pedemonte WA; Mosnaim AD; Bulat M
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):111-6. PubMed ID: 935645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
    Korf J; van Praag HM; Sebens JB
    Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
    Guldberg HC; Ashcroft GW; Crawford TB
    Life Sci; 1966 Sep; 5(17):1571-5. PubMed ID: 5970680
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.